FIRST SOLAR INC (FSLR)       179.35  +3.92 (+2.23%)

179.35  +3.92 (+2.23%)

US3364331070 - Common Stock - After market: 179.35 0 (0%)


Fundamental Rating

3

Taking everything into account, FSLR scores 3 out of 10 in our fundamental rating. FSLR was compared to 107 industry peers in the Semiconductors & Semiconductor Equipment industry. FSLR scores bad on very profitability, while its financial health is fine. Not spectacular, but in line with the averages. FSLR is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

0

FSLR's Return On Assets of 1.26% is worse than the rest of the industry. The industry average Return On Assets is 11.42%. 99% of the industry peers have a better Return On Assets.
FSLR's Return On Equity of 1.63% is worse than the rest of the industry. The industry average Return On Equity is 21.21%. 99% of the industry peers have a better Return On Equity.

FSLR's Profit Margin of 3.75% is worse than the rest of the industry. The industry average Profit Margin is 18.83%. 95% of the industry peers have a better Profit Margin.
FSLR has a very weak Piotroski-F score of 1.00. This is an indication of health and profitability issues for FSLR.
VS Industry

ROA (1.26%) VS Industry: 1% outperformed.

0.20
34.75

ROE (1.63%) VS Industry: 1% outperformed.

1.44
156.01

Profit Margin (3.75%) VS Industry: 5% outperformed.

0.27
65.16

Valuation

Valuation Rating

1

When comparing the current price to the book value of FSLR, we can conclude it is valued correctly. It is trading at 3.28 times its book value.
When comparing the price book ratio of FSLR to the average industry price book ratio of 3.41, FSLR is valued in line with its industry peers.
The Price/Earnings Ratio is negative for FSLR. In the last year negative earnings were reported.

With a Forward Price/Earnings Ratio of 45.57, FSLR is valued very expensively.
When comparing the Enterprise Value to EBITDA ratio of FSLR to the average industry ratio of 12.48, FSLR is valued more expensive than its industry peers. 95% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Book (3.28) VS Industry: 56% outperformed.

1,616.39
0.47

Enterprise Value/ EBITDA (63.93) VS Industry: 5% outperformed.

1,552.65
0.11

Growth

Growth Rating

6

Based on estimates for the next 5 years, FSLR will show a very strong growth in Earnings Per Share. The EPS will grow by 43.60% on average per year.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
FSLR is expected to show quite a strong growth in Revenue. In the coming 5 years, the Revenue will grow by 16.12% yearly.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.

FSLR shows a decrease in Earnings Per Share. Measured over the last 5 years, the EPS has been decreasing by -8.39% yearly.
The Revenue has decreased by -3.85% in the past year.
Measured over the past 5 years, FSLR shows a small growth in Revenue. The Revenue has been growing by 0.13% on average per year.
FSLR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -101.30%.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-8.39% 33.61% -101.3% -115.74% 10.56% 47.31% 43.6%
Revenue0.13% 9.22% -3.85% -10.73% 7.2% 15.46% 16.12%

Health

Health Rating

6

FSLR has a Current Ratio of 4.09. This indicates that FSLR is financially healthy and has no problem in meeting its short term obligations.
The Current Ratio of FSLR is much better than the industry average of 3.15.
FSLR has a Quick Ratio of 3.10. This indicates that FSLR is financially healthy and has no problem in meeting its short term obligations.
An Altman-Z score of 8.22 indicates that FSLR is not in any danger for bankruptcy at the moment.

When comparing the Altman-Z score to an average industry score of 4.56, FSLR is in better financial health than the average industry peer.
The Quick Ratio is in line with the industry averages, which is at 2.35.
The Debt to Equity ratio of FSLR is in line with the industry averages.
FSLR has a very weak Piotroski-F score of 1.00. This is an indication of health and profitability issues for FSLR.
VS Industry

Debt/Equity (0.04) VS Industry: 59% outperformed.

135.78
0.00

Quick Ratio (3.1) VS Industry: 60% outperformed.

0.32
20.10

Current Ratio (4.09) VS Industry: 68% outperformed.

0.46
20.10

Altman-Z (8.22) VS Industry: 75% outperformed.

-61.75
56.83

Dividend

Dividend Rating

0

FSLR does not give a dividend.

FIRST SOLAR INC179.35

NASDAQ:FSLR (1/27/2023, 7:09:04 PM)+3.92 (+2.23%)

After market: 179.35 0 (0%)

Chartmill FA Rating
GICS Sector Information Technology
GICS IndustryGroup Semiconductors & Semiconductor Equipment
GICS Industry Semiconductors & Semiconductor Equipment
Earnings (Last) 10-27 2022-10-27/amc Earnings (Next) 02-27 2023-02-27
Inst Owners 78.56% Inst Owner Change 0.05%
Ins Owners 0.3% Ins Owner Change 2.41%
Market Cap 19.12B Analysts 77.65
Price Target 169.72 (-5.37%)

Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) -211.37%
Min EPS beat(2) -357.22% Max EPS beat(2) -65.52%
EPS beat(4) 2 Avg EPS beat(4) -101.23%
Min EPS beat(4) -357.22% Max EPS beat(4) 13.55%
Revenue beat(2) 1 Avg Revenue beat(2) -8.42%
Min Revenue beat(2) -17.63% Max Revenue beat(2) 0.79%
Revenue beat(4) 1 Avg Revenue beat(4) -14.8%
Min Revenue beat(4) -39.29% Max Revenue beat(4) 0.79%
PT rev (1m) 3.33% EPS NQ rev (1m) 0%
EPS NY rev (1m) 0% Revenue NQ rev (1m) 0%
Revenue NY rev (1m) 0%

Valuation
Industry RankSector Rank
PE N/A
Fwd PE 45.57
P/S 7.57
P/FCF N/A
P/OCF N/A
P/B 3.28
P/tB 3.31
EV/EBITDA 63.93
EPS(TTM) -0.04 EY N/A
EPS(NY) 3.94 Fwd EY 2.19%
FCF(TTM) -7.79 FCFY N/A
OCF(TTM) -0.56 OCFY N/A
SpS 23.68 BVpS 54.67
TBVpS 54.19 PEG (NY) N/A
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA 1.26%
ROE 1.63%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM 3.75%
GM 12.42%
ROICexgc(3y) N/A ROICexcg growth 3Y N/A
ROICexcg growth 5Y N/A ROICexc(3y) N/A
ROICexc growth 3Y N/A ROICexc growth 5Y N/A
OM growth 3Y 103.38% OM growth 5Y 11.75%
PM growth 3Y 35.6% PM growth 5Y N/A
GM growth 3Y 12.63% GM growth 5Y 2.58%
F-Score 1 Asset Turnover 0.34

Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 1
Cap/Depr 291.74%
Profit Quality N/A
Current Ratio 4.09
Quick Ratio 3.1
Altman-Z 8.22
F-Score 1 WACC 11.14%
ROIC/WACC N/A Cap/Depr(3y) N/A
Cap/Depr(5y) N/A Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y -101.3% EPS 3Y 33.61%
EPS 5Y -8.39% EPS growth Q2Q -209.52%
EPS Next Y -115.74% EPS Next 2Y 10.56%
EPS Next 3Y 47.31% EPS Next 5Y 43.6%
Revenue growth 1Y -3.85% Revenue growth 3Y 9.22%
Revenue growth 5Y 0.13% Revenue growth Q2Q 7.79%
Revenue Next Year -10.73% Revenue Next 2Y 7.2%
Revenue Next 3Y 15.46% Revenue Next 5Y 16.12%
EBIT growth 1Y -101.12% EBIT growth 3Y 122.12%
EBIT growth 5Y 11.89% EBIT Next Year -59.19%
EBIT Next 3Y 38.38% EBIT Next 5Y 39.88%
FCF growth 1Y -664.9% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y -109.39%
OCF growth 3Y N/A OCF growth 5Y 2.81%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA